Wegovy Injections for Weight Loss

Wegovy in stock near me

Losing weight and keeping it off is a struggle for many patients. At Weight Loss Clinic Los Angeles, we understand the frustration of our patients, and we’re here to help. Under the expert care of Dr. David Nazarian, we provide customized plans combining Bioidentical Hormone Replacement Therapy (BHRT) with the latest medical therapies for sustained weight loss.

Our special pharmacy compounded Wegovy injection is in stock and can be shipped to your door if you qualify for this weight loss injection.  Wegovy, is approved specifically for weight management in adults. Wegovy works by tapping into appetite signaling pathways, helping patients feel satiated with less food intake. In clinical trials, over 60% of patients have achieved over 15% body weight reduction with Wegovy over a year or more, a level far exceeding other therapies.

What is Wegovy?

Wegovy (semaglutide) is approved for use in adults with obesity or overweight with at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol.

Approved by the FDA, Wegovy works by mimicking a hormone called GLP-1 that targets areas of the brain that regulate appetite and food intake. It helps a person feel full sooner and for longer, leading them to eat less. It also slows stomach emptying to promote fullness.

In a clinical study, people taking Wegovy lost, on average, 5-20% of their body weight over 68 weeks when used along with diet and exercise [1]. Like other weight loss medications, it’s meant to be used along with lifestyle changes.

Understanding Wegovy (Semaglutide) and Its Mechanism

Wegovy contains the active drug semaglutide, which belongs to a class of medications called GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1, which is a hormone released naturally in the body after eating [2].

GLP-1 has several effects that together promote weight loss:

1. Slows stomach emptying: By slowing the rate at which food empties from your stomach into the small intestine, it helps you feel fuller longer after meals. This controls hunger.

1. Increases satiety signals: It activates receptors in the brain that control feelings of fullness and satiety or satisfaction from food. This helps curb excessive eating.

1. Lowers appetite: It reduces appetite signals in areas of the brain like the hypothalamus and brain stem, which regulate food intake behavior. People have less motivation to eat more.
2. Regulates blood sugar: It balances blood sugar levels by stimulating insulin when blood sugar is high while also inhibiting the release of glucagon, which raises blood sugar. This helps control diabetes.

Efficacy and Benefits of Wegovy Injections

Wegovy has been shown to be quite effective for weight loss in clinical trials, leading to significant reductions in body weight and BMI along with other health benefits when used properly:

Study 1 (1,961 adults):

• Wegovy users lost an average of 15% of their body weight after 68 weeks.
• Placebo users only lost about 2% of their body weight.
• 84% of Wegovy users achieved at least a 5% weight loss, compared to 31% with placebo.

Study 2 (611 adults with counseling):

• Wegovy users lost an average of 16% of their body weight after 68 weeks.
• Placebo users lost around 6% of their body weight.
• 85% of Wegovy users achieved at least a 5% weight loss, compared to 48% with placebo.

Study 3 (902 adults maintaining weight loss):

• Wegovy users continued losing weight, with an additional 8% reduction in body weight after 48 more weeks.
• Placebo users regained 7% of their body weight after stopping Wegovy, indicating the need to continue Wegovy to avoid weight regain.

Type 2 Diabetes Patients Study:

Study 4 (1,210 adults with type 2 diabetes):

• Wegovy users lost an average of 10% of their body weight after 68 weeks.
• Placebo users only lost about 3% of their body weight.
• 67% of Wegovy users achieved at least a 5% weight loss, compared to 30% with placebo.

Adolescent Study:

Adolescent Study (200 participants aged 12 to less than 18 years):

• Those treated with Wegovy experienced a BMI drop by an average of 16% after 68 weeks [3].
• Participants who received a placebo had an average BMI increase of less than 1%.
• About 73% of Wegovy users lost at least 5% of their weight, while around 18% of placebo users achieved the same.

Wegovy where to buy